Bill > LD627

This bill requires health insurance carriers in Maine to provide coverage for glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications, which are a type of prescription drug approved by the FDA, when prescribed by a healthcare provider. Specifically, the bill mandates that carriers cannot charge enrollees more than $35 per 30-day prescription for these medications and prohibits carriers from imposing prior authorization requirements before covering the drugs. The legislation also requires the Bureau of Insurance to launch a public education campaign by November 1, 2025, to inform healthcare providers and the public about the new coverage requirements and the health benefits of GLP-1 RA medications. These requirements will apply to all health insurance policies, contracts, and certificates issued or renewed in the state on or after January 1, 2026. GLP-1 RA medications are typically used to treat conditions like type 2 diabetes and obesity, and this bill aims to improve access to these potentially life-changing treatments by reducing financial barriers.

Health and Social Services

https://legislature.maine.gov/legis/bills/display_ps.asp?LD=627&snum=132